E.S. Barr & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.88M | Hold |
3,236
| – | – | 0.22% | 36 |
|
|
2026
Q1 | $2.98M | Sell |
3,236
-5
| -0.2% | -$5.07K | 0.17% | 42 |
|
|
2025
Q4 | $3.48M | Sell |
3,241
-70
| -2% | -$66.9K | 0.18% | 39 |
|
|
2025
Q3 | $2.53M | Hold |
3,311
| – | – | 0.14% | 44 |
|
|
2025
Q2 | $2.58M | Buy |
3,311
+70
| +2% | +$54.4K | 0.15% | 42 |
|
|
2025
Q1 | $2.68M | Sell |
3,241
-5
| -0.2% | -$4.16K | 0.16% | 42 |
|
|
2024
Q4 | $2.51M | Sell |
3,246
-29
| -0.9% | -$24K | 0.15% | 44 |
|
|
2024
Q3 | $2.9M | Buy |
3,275
+14
| +0.4% | +$12.6K | 0.18% | 42 |
|
|
2024
Q2 | $2.95M | Hold |
3,261
| – | – | 0.19% | 40 |
|
|
2024
Q1 | $2.54M | Hold |
3,261
| – | – | 0.17% | 43 |
|
|
2023
Q4 | $1.9M | Sell |
3,261
-125
| -4% | -$73K | 0.13% | 45 |
|
|
2023
Q3 | $1.82M | Hold |
3,386
| – | – | 0.13% | 44 |
|
|
2023
Q2 | $1.59M | Buy |
3,386
+274
| +9% | +$115K | 0.12% | 48 |
|
|
2023
Q1 | $1.07M | Hold |
3,112
| – | – | 0.09% | 49 |
|
|
2022
Q4 | $1.14M | Hold |
3,112
| – | – | 0.09% | 50 |
|
|
2022
Q3 | $1.01M | Hold |
3,112
| – | – | 0.09% | 54 |
|
|
2022
Q2 | $1.01M | Sell |
3,112
-100
| -3% | -$30K | 0.08% | 55 |
|
|
2022
Q1 | $920K | Sell |
3,212
-1,000
| -24% | -$257K | 0.06% | 57 |
|
|
2021
Q4 | $1.16M | Sell |
4,212
-13
| -0.3% | -$3.3K | 0.08% | 54 |
|
|
2021
Q3 | $976K | Buy |
4,225
+13
| +0.3% | +$3.21K | 0.07% | 54 |
|
|
2021
Q2 | $967K | Buy |
4,212
+2,000
| +90% | +$402K | 0.07% | 52 |
|
|
2021
Q1 | $413K | Hold |
2,212
| – | – | 0.03% | 66 |
|
|
2020
Q4 | $373K | Hold |
2,212
| – | – | 0.03% | 65 |
|
|
2020
Q3 | $327K | Hold |
2,212
| – | – | 0.03% | 66 |
|
|
2020
Q2 | $363K | Hold |
2,212
| – | – | 0.04% | 66 |
|
|
2020
Q1 | $307K | Hold |
2,212
| – | – | 0.04% | 69 |
|
|
2019
Q4 | $291K | Hold |
2,212
| – | – | 0.03% | 70 |
|
|
2019
Q3 | $247K | Hold |
2,212
| – | – | 0.02% | 73 |
|
|
2019
Q2 | $245K | Hold |
2,212
| – | – | 0.02% | 73 |
|
|
2019
Q1 | $287K | Buy |
2,212
+50
| +2% | +$6.08K | 0.03% | 68 |
|
|
2018
Q4 | $250K | Hold |
2,162
| – | – | 0.03% | 74 |
|
|
2018
Q3 | $232K | Buy |
+2,162
| New | +$216K | 0.02% | 85 |
|
Other funds holding LLY
E.S. Barr & Co's LLY Position: Q2 2026 in Review
E.S. Barr & Co held its Eli Lilly (LLY) position steady in Q2 2026 at 3,236 shares worth $3.88M. The position accounts for 0.22% of the portfolio, ranked #36.
E.S. Barr & Co first reported a position in LLY in Q3 2018 and has held it in 32 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- E.S. Barr & Co held 3,236 shares of Eli Lilly worth $3.88M as of Q2 2026.
- E.S. Barr & Co left its Eli Lilly share count unchanged in Q2 2026.
- Eli Lilly made up 0.22% of E.S. Barr & Co's portfolio in Q2 2026, its #36 holding.
- E.S. Barr & Co first reported a position in Eli Lilly in Q3 2018 and has held it in 32 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on E.S. Barr & Co's 13F filing for Q2 2026, filed 13 Aug 2026.